Search

Paul Makidon Phones & Addresses

  • Corpus Christi, TX
  • Pacifica, CA
  • 1780 Creekside Dr APT 2224, Folsom, CA 95630 (734) 277-5775
  • Pleasant Prairie, WI
  • Pinckney, MI
  • Woburn, MA
  • Webberville, MI
  • Ann Arbor, MI
  • Davison, MI
  • Pleasant Pr, WI
  • 11790 Weiman Dr, Pinckney, MI 48169

Work

Company: Abbvie Nov 2015 Position: Senior principal research scientist

Education

Degree: Graduate or professional degree

Skills

Research • Science • Life Sciences • Clinical Research • Higher Education • Teaching • Animal Models • Biotechnology • University Teaching • Statistics • Medicine • Molecular Biology • Qualitative Research • Assay Development • Student Development • Immunology • Cell Culture • Student Affairs • Biomedical Engineering • Surgery

Interests

Social Services • Children • Economic Empowerment • Civil Rights and Social Action • Education • Environment • Poverty Alleviation • Science and Technology • Disaster and Humanitarian Relief • Human Rights • Animal Welfare • Arts and Culture • Health

Industries

Research

Resumes

Resumes

Paul Makidon Photo 1

Director Of Comparative Medicine

View page
Location:
229 Marvilla Cir, Pacifica, CA 94044
Industry:
Research
Work:
Abbvie
Senior Principal Research Scientist

University of Michigan Jun 1, 2008 - Nov 2015
Assistant Professor

Professional Lab Animal Colleague We Have Not Worked Together 2009 - 2015
Associate Director - In Vivo Animal Core - Assistant Professor - University of Michigan

2009 - 2015
Director of Comparative Medicine
Skills:
Research
Science
Life Sciences
Clinical Research
Higher Education
Teaching
Animal Models
Biotechnology
University Teaching
Statistics
Medicine
Molecular Biology
Qualitative Research
Assay Development
Student Development
Immunology
Cell Culture
Student Affairs
Biomedical Engineering
Surgery
Interests:
Social Services
Children
Economic Empowerment
Civil Rights and Social Action
Education
Environment
Poverty Alleviation
Science and Technology
Disaster and Humanitarian Relief
Human Rights
Animal Welfare
Arts and Culture
Health

Publications

Us Patents

Nanoemulsion Adjuvants

View page
US Patent:
20090291095, Nov 26, 2009
Filed:
May 26, 2009
Appl. No.:
12/472013
Inventors:
Paul E. Makidon - Webberville MI, US
Nicholas J. Mank - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/00
US Classification:
4241841
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and adaptive immune responses (e.g., for generation of host immunity against an environmental pathogen)). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.

Immunogenic Compositions Comprising Nanoemulsion And Hepatitis B Virus Immunogen And Methods Of Using The Same

View page
US Patent:
20100028433, Feb 4, 2010
Filed:
May 26, 2009
Appl. No.:
12/472223
Inventors:
Anna U. Bielinska - Ypsilanti MI, US
Nicholas J. Mank - Ann Arbor MI, US
Paul E. Makidon - Webberville MI, US
Zhengyi Cao - Ann Arbor MI, US
Alison J. Scott - North Bethesda MD, US
Shraddha S. Nigavekar - Franklin TN, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 9/107
A61K 39/29
US Classification:
424484, 4242271
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides immunogenic compositions and methods of using the same to induce immune responses (e.g., immunity (e.g., protective immunity)) against Hepatitis B virus (HBV)). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.

Nanoemulsion Therapeutic Compositions And Methods Of Using The Same

View page
US Patent:
20100203139, Aug 12, 2010
Filed:
Sep 25, 2009
Appl. No.:
12/567571
Inventors:
Mark R. Hemmila - Superior Township MI, US
Stewart C. Wang - Ann Arbor MI, US
Tarek Hamouda - Milan MI, US
John J. LiPuma - Ann Arbor MI, US
Jessica A. Knowlton - Ypsilanti MI, US
Paul E. Makidon - Webberville MI, US
Luz P. Blanco - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 9/107
A61K 39/02
A61P 31/04
US Classification:
424484, 4242341, 4241901
Abstract:
The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a antigen) that generate an effective immune response (e.g., against a bacterial species of the genus ) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.

Multivalent Nanoemulsion Vaccines

View page
US Patent:
20120107349, May 3, 2012
Filed:
May 26, 2009
Appl. No.:
12/472218
Inventors:
Paul E. Makidon - Webberville MI, US
Nicholas J. Mank - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Luz P. Blanco - Ann Arbor MI, US
Jessica A. Knowlton - Ypsilanti MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/116
A61P 31/04
US Classification:
4242031
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus, , Hepatits B, and/or HIV, etc.) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., immunogenic composition comprising nanoemulsion and one or a plurality of pathogens (e.g., inactivated by the nanoemulsion) and/or pathogen products and/or pathogen components). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications

Streptococcus Vaccine Compositions And Methods Of Using The Same

View page
US Patent:
20120128719, May 24, 2012
Filed:
May 14, 2010
Appl. No.:
13/320205
Inventors:
Paul E. Makidon - Webberville MI, US
Whitney A. Dunlap - Jacksonville FL, US
Jessica A. Knowlton - Cordova TN, US
Benjamin Swanson - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/09
A61P 31/04
A61K 39/02
B82Y 5/00
US Classification:
4242361, 4242441, 977788, 977917
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against a bacterial species of the genus (e.g., ))). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.

Immunogenic Compositions Comprising Nanoemulsion And Hepatitis B Virus Immunogen And Methods Of Using The Same

View page
US Patent:
20120258137, Oct 11, 2012
Filed:
Jun 4, 2012
Appl. No.:
13/487925
Inventors:
Douglas Smith - Ann Arbor MI, US
Paul E. Makidon - Webberville MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/29
A61P 31/12
US Classification:
4242271
Abstract:
The invention provides immunogenic compositions and methods of using the same to induce immune responses (e.g., humoral, mucosal, and/or cell-mediated immune responses) against Hepatitis B virus (HBV)). Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination (e.g., of patient populations at risk for acute and/or chronic HBV infection))) and research applications.

Immunogenic Apoptosis Inducing Compositions And Methods Of Use Thereof

View page
US Patent:
20130273113, Oct 17, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/836617
Inventors:
Paul Makidon - Webberville MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/39
US Classification:
4242781
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., immunologic cell death/apoptosis (e.g., for the induction of innate and/or adaptive immune responses)). Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., for infectious disease, cancer, autoimmunity, and/or tissue injury (e.g., via alteration of host immune responses))) and research applications.

Nanoemulsion Therapeutic Compositions And Methods Of Using The Same

View page
US Patent:
20080317799, Dec 25, 2008
Filed:
May 2, 2008
Appl. No.:
12/114573
Inventors:
James R. Baker - Ann Arbor MI, US
Sivaprakash Rathinavelu - Naperville IL, US
Paul E. Makidon - Webberville MI, US
John J. LiPuma - Ann Arbor MI, US
Shraddha Nigavekar - Columbia TN, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A01N 25/04
A61K 9/12
A01N 25/06
A61K 9/107
A61P 31/00
A01P 1/00
US Classification:
424405, 424 45, 424400
Abstract:
The present invention relates to methods and compositions for treating pulmonary infection. In particular, the present invention provides nanoemulsion compositions and methods of using the same to treat bacteria associated with biofilms (e.g., found in pulmonary infections). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.

Isbn (Books And Publications)

Emergency And Critical Care Management for Laboratory Animals

View page
Author

Paul Makidon

ISBN #

0849324998

Paul E Makidon from Corpus Christi, TX, age ~55 Get Report